Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Agenus Inc. logo

Agenus Inc.

Sector: Healthcare   

Industry: Biotechnology

7.42
 
USD
  
0.96
  
(14.86%)
Optionable: Yes  Market Cap: 135 M  90-day average vol: 673,461

Previous close: 6.46  Open: 6.84  Bid: 7.42  Ask: 7.45
52 week range    
4.78   
   42.60
Peers   
IDRA / 
NWBO / 
MRK / 
PARD / 
GSK / 
IMUC / 
BMY / 
CLDX / 
Last updated: Thursday 25th April 2024
34
MarketXLS Rank
40
Value
38
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMY

0.0332145 B-27.366.19

CLDX

1 B-17.331.4

GSK

IDRA

0 B-0.20.5451

IMUC

0 B0.10.2295

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NWBO

1 B-2.30.908

PARD

Financials

AGEN Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0213000.0
Amortization of intangibles-462000.0-525000.0-2 M-2 M-2 M23 M25 M25 M25 M-805000.0
Basic EPS from continuing operations-0.8-1.05-0.11-0.78-0.69
Basic EPS total-0.72-0.8-1.05-0.11-0.78-0.69
Basic weighted shares outstanding60 M78 M87 M98 M110772.0134982.0172504.0228919.0281743.0357889.0
Cost of sales2 M3 M11 M3 M
Depreciation-1 M-1 M-3 M-4 M-4 M5 M5 M5 M5 M12 M
DepreciationAndAmortization-1 M-1 M-3 M-4 M-4 M5 M5 M5 M5 M12 M
DevelopmentExpense3 M
Diluted EPS total-0.71-1.13-1.46-1.23-1.44-0.8-1.05-0.11-0.78-0.69
Diluted normalized net income/share-1.44-0.78-0.69
Diluted weighted shares outstanding60 M78 M87 M98 M110772.0134982.0172504.0228919.0281743.0357889.0
Fees-2 M-3 M
GeneralAndAdministrativeExpense21 M28 M33 M34 M37 M46 M59 M76 M81 M79 M
Gross operating profit7 M25 M23 M43 M37 M150 M86 M292 M87 M153 M
ImpairmentOfCapitalAssets6 M
Income before tax-42 M-93 M-127 M-121 M-162 M-112 M-180 M-29 M-229 M-257 M
Income restructuring and M&A43 M
Income taxes-5 M-7 M-105 M-10 M-4 M-3 M-3 M
Interest income834708.0-13 M-20 M-17 M-27 M-41 M-61 M-66 M-62 M-98 M
InterestExpenseNonOperating1 M-4 M-19 M-31 M2 M
MinorityInterests2 M4 M2 M5 M11 M12 M
MiscOtherSpecialCharges-7 M-7 M-2 M3 M-9 M28000.0-2 M11 M13 M37000.0
Net income from total operations-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M-246 M
NetIncomeCommonStockholders-43 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M-246 M
NetIncomeContinuousOperations-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M-246 M
NetIncomeFromOtherGainsLosses-3 M-2 M
NetNonOperatingInterestIncomeExpense834708.0-13 M-20 M-17 M-27 M-41 M-63 M-66 M-62 M-98 M
Normalized income-203 M
Operating income-37 M-74 M-106 M-107 M-125 M-70 M-117 M26 M-179 M-160 M
Operating income before depreciation (EBITDA)-41 M-96 M-141 M-146 M-156 M-105 M-171 M-22 M-222 M-244 M
OperatingExpense44 M99 M128 M150 M162 M214 M202 M258 M278 M316 M
Other income net7 M7 M2 M-3 M9 M6 M3 M233000.0-13 M-593000.0
Other special charges-365000.0-780000.0-733000.0-562000.0-541000.0
OtherGandA21 M28 M33 M34 M37 M46 M59 M76 M81 M79 M
OtherImpairmentOfCapitalAssets6 M
OtherOperatingExpenses-90000.0-203000.0-122000.06 M3 M12 M18 M
OtherTaxes11 M
OtherunderPreferredStockDividend203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0213000.0
PreferredStockDividends203832.0202960.0204246.0205541.0207000.0208000.0209000.0211000.0212000.0213000.0
RentAndLandingFees21 M28 M33 M34 M-2 M
Research & development expense22 M70 M95 M116 M125 M168 M143 M179 M187 M238 M
ResearchExpense22 M70 M95 M116 M125 M168 M143 M179 M187 M235 M
RestructringAndMnAIncome43 M
Revenue per share-462000.0-525000.0-2 M-2 M-2 M23 M25 M25 M25 M2 M
SalariesAndWages-5 M-7 M-13 M-12 M-8 M357000.0621000.06 M11 M12 M
SecuritiesAmortization11 M
Selling Gen & administrative expense21 M28 M33 M34 M37 M46 M59 M76 M81 M79 M
Special income/charges-43 M780000.0733000.0562000.0541000.0-6 M
Total Income available for interest expense (EBIT)-42 M-98 M-146 M-152 M-162 M-112 M-178 M-29 M-229 M-257 M
Total common shares outstanding71 M87 M98 M103 M134 M162 M205 M257 M333 M419 M
Total net income-42 M-88 M-127 M-121 M-160 M-108 M-181 M-24 M-220 M-246 M
Total ordinary shares419 M419 M419 M419 M419 M419 M419 M419 M419 M419 M
Total revenues7 M25 M23 M43 M37 M150 M88 M296 M98 M156 M
TotalExpenses44 M99 M128 M150 M162 M214 M204 M262 M289 M320 M
TotalRevenue7 M25 M23 M43 M37 M150 M88 M296 M98 M156 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University